about ▼
our story
team
join us
our story
platform ▼
platform
publications
programs▼
pipeline
clinical studies
team
join us
platform
publications
programs
clinical studies
press releases
in the news
alto in mind
press & news ▼
press releases
in the news
alto in mind
about ▼
our story
team
join us
platform ▼
platform
publications
programs ▼
pipeline
clinical studies
our story
team
join us
platform
publications
programs
clinical studies
press releases
in the news
alto in mind
press & news ▼
press releases
in the news
alto in mind
Press Releases
All Press Releases
2023
2022
2021
February 7, 2023
2023
February 7, 2023
Erin R. McQuade, J.D., Joins Alto Neuroscience as General Counsel and Chief Administrative Officer
January 30, 2023
2023
January 30, 2023
Alto Neuroscience Announces $60 Million in Additional Financing
January 10, 2023
2023
January 10, 2023
Alto Neuroscience Announces Positive Results for ALTO-100 in Phase 2 Study Supporting Advancement of First-in-Class Mechanism for Treating Depression
December 23, 2022
2022
December 23, 2022
Alto Neuroscience to Present at the 41st Annual J.P. Morgan Healthcare Conference
December 14, 2022
2022
December 14, 2022
Alto Neuroscience Announces Positive Data from Phase 1 Study Evaluating Brain Effects of Novel Drug Combinations
December 8, 2022
2022
December 8, 2022
Alto Neuroscience Presents New Data Leveraging EEG and Machine Learning to Predict Individual Response to Antidepressants at the 61st Annual Meeting of the American College of Neuropsychopharmacology
Previous
Load more
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Receive updates from Alto
Thanks for signing up!
Oops! Something went wrong while submitting the form.
Privacy Policy
Terms of Use
© Alto Neuroscience 2023